<DOC>
	<DOC>NCT00532935</DOC>
	<brief_summary>A study to evaluate the efficacy and safety of MK0431A in comparison to a commonly used medication in patients with type 2 diabetes</brief_summary>
	<brief_title>MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>General Patient has type 2 diabetes mellitus Patient is inadequately controlled and not on treatment with insulin or oral antihyperglycemic therapy General Patient has a history of type 1 diabetes mellitus or history of ketoacidosis Patient was on antihyperglycemic agent therapy (oral or insulin) within the prior 12 weeks Patient was on &gt;4 weeks (cumulatively) of antihyperglycemic therapy (oral or insulin) over the prior 3 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>